Keywords: AREDS; Alpha Agonists; Alphagan; Antioxidants; Artificial Tears; Avastin; Azasite; Azopt; Bacterial Conjunctivitis; Beovu; Besivance; Betagan; Betimol; Betoptic; Carbonic Anhydrase Inhibitors; Cequa; Cholinergic Agonists; Ciloxan; Combigan; Cosopt; Eylea; Haemophilus influenzae; Iopidine; Istalol; Izba; Laser Trabeculoplasty; Lucentis; Lumigan; MVASI; Macugen; Marijuana; Monoprost; Moxeza; Ocuflox; Ophthalmic Antibacterials; Photodynamic Therapy; Prostaglandin Analogs; Restasis; Rho Kinase Inhibitor; Rhopressa; Rocklatan; Streptococcus pneumoniae; Timoptic; Topical Cyclosporine; Travatan; Trusopt; VEGF Inhibitors; Vigamox; Vistitan; Visudyne; Vyzulta; Xalatan; Xelpros; Xiidra; Zioptan; Zirabev; Zymaxid; adverse effects; aflibercept; age-related macular degeneration; apraclonidine; azithromycin; bacitracin; besifloxacin; beta blockers; beta carotene; betaxolol; bevacizumab; bimatoprost; brimonidine; brimonidine/timolol; brinzolamide; brinzolamide/brimonidine; brolucizumab; cannabidiol; cannabis; carteolol; ciprofloxacin; conjunctivitis; cyclosporine; dorzolamide; dosage; dry eye disease; efficacy; erythromycin; eye; fluoroquinolones; gatifloxacin; gentamicin; glaucoma; latanoprost; latanoprost/netarsudil; latanoprostene bunod; levobunolol; levofloxacin; lifitegrast; metipranolol; moxifloxacin; neomycin; netarsudil; ofloxacin; omega-3 fatty acids; pegaptanib; ranibizumab; safety; sulfacetamide; surgery; tafluprost; timolol; timolol/dorzolamide; tobramycin; travoprost; verteporfin; vitamin supplements; zinc.